Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus

Medicine & Life Sciences

• Area Under Curve 12%
• Blood Glucose 3%
• Body Mass Index 2%
• Body Weight 2%
• Cross-Over Studies 3%
• Enzymes 2%
• Glucagon-Like Peptide 1 100%
• glucagon-like peptide 1 (7-36)amide 6%
• Glucose 53%
• Hemoglobins 3%
• Hormones 2%
• Incretins 5%
• Insulin 5%
• Intravenous Infusions 3%
• Meals 3%
• Metformin 91%
• Placebos 2%
• Serum 38%
• Subcutaneous Injections 8%
• Tablets 3%
• Therapeutics 1%
• Type 2 Diabetes Mellitus 64%